GI
TYRA icon

GAMMA Investing’s Tyra Biosciences TYRA Stock Holding History

GAMMA Investing’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.1K Sell
505
-1
-0.2% -$33 ﹤0.01% 2960
2026
Q1 		$19.4K Buy
506
+34
+7% +$1.1K ﹤0.01% 2728
2025
Q4 		$12.4K Buy
472
+161
+52% +$2.96K ﹤0.01% 2871
2025
Q3 		$4.35K Buy
311
+96
+45% +$1.09K ﹤0.01% 3233
2025
Q2 		$2.06K Buy
+215
New +$2.04K ﹤0.01% 3391
2025
Q1 		– Sell
-26
Closed -$361 – 3884
2024
Q4 		$361 Sell
26
-57
-69% -$1.03K ﹤0.01% 3634
2024
Q3 		$1.95K Buy
83
+48
+137% +$1.01K ﹤0.01% 3075
2024
Q2 		$560 Buy
35
+19
+119% +$327 ﹤0.01% 3191
2024
Q1 		$262 Hold
16
– – ﹤0.01% 3201
2023
Q4 		$214 Buy
+16
New +$207 ﹤0.01% 3114

Other funds holding TYRA

APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AI
Auour Investments Woburn, Massachusetts $349M AUM 13.68% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's TYRA Position: Q2 2026 in Review

GAMMA Investing reduced its Tyra Biosciences (TYRA) stake by 0.2% in Q2 2026, selling an estimated $33 and leaving 505 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2960.

GAMMA Investing first reported a position in TYRA in Q4 2023 and has held it in 10 quarters since. The position peaked at $19.4K in Q1 2026. 16 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • GAMMA Investing held 505 shares of Tyra Biosciences worth $16.1K as of Q2 2026.
  • GAMMA Investing sold 1 Tyra Biosciences share in Q2 2026, an estimated $33.
  • Tyra Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2960 holding.
  • GAMMA Investing first reported a position in Tyra Biosciences in Q4 2023 and has held it in 10 quarters since.
  • GAMMA Investing's Tyra Biosciences position peaked at $19.4K in Q1 2026.
  • 16 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.